H3N2 Influenza-A Virus New York/55/04 Recombinant, H3N2 New-York, 10ug

CAT No.BT-IHA-011

H3N2 Influenza-A Virus New York/55/04 Recombinant, H3N2 New-York, 10ug

---

Description
Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is 70,000 dalton.

Immunological Activity
Western-Blot 0.1ug -1ug per strip, ELISA 1ug/Well.

Physical Appearance
Sterile Filtered colorless solution FormulationThe Recombinant H3N2 A/New-York/55/04 solution contains 30mM Sodium phosphate, pH 7.4 and 500mM NaCl.

Greater than 90.0% as determined by SDS-PAGE.

Source
Baculovirus Insect Cells.

Stability
H3N2 A/New-York/55/04 Recombinant should be stored at 4¡ãC.

Usage
TSZGENE's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.